Navigation Links
Study shows physicians reluctant to use chemoprevention for prostate cancer
Date:8/10/2010

PHILADELPHIA Despite the dramatic results of the Prostate Cancer Prevention Trial (PCPT), which showed a significant reduction in prostate cancer among those taking finasteride, physicians have not increased its use, according to a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

The first results of the PCPT were published in 2003 in The New England Journal of Medicine and were widely reported. The randomized controlled trial consisted of 18,000 men and showed a 25 percent reduced risk of prostate cancer.

Unfortunately, it also showed a 27 percent increased risk in high-grade tumors, which was noted in an accompanying editorial. Ian Thompson, M.D., chairman of the department of urology at the University of Texas Health Science Center, who led the study, said the editorial may have colored the perception of finasteride.

"People tend to read editorials more than they read actual journal articles," said Thompson. "The study paradox of a reduction in overall disease, but an increase in high-grade disease was not explored until much later."

In 2008, another report was published in Cancer Prevention Research, another journal of the AACR, where Thompson and colleagues reanalyzed the data along with the available tumor biopsies. Results showed that finasteride did not actually increase risk; it just made the available testing more sensitive. This result confirmed the benefits of finasteride for prostate cancer prevention.

However, results of this new study showed that physicians have not changed their practice patterns.

Linda Kinsinger, M.D., M.P.H., chief consultant for preventive medicine at the Veterans Health Administration National Center for Health Promotion and Disease Prevention, and colleagues surveyed 325 urologists and 1,200 primary care physicians to determine their prescribing pa
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Many Stroke Patients Stop Taking Meds, Study Shows
2. UC Denver study finds beautiful women face discrimination in certain jobs
3. Surgery better than radiation, hormone treatments for some prostate cancer, study shows
4. Tattooing linked to higher risk of hepatitis C: UBC study
5. Women Can Safely Get Pregnant Right After Miscarriage, Study Shows
6. Type 2 Diabetes Might Harm Young Brain, Study Suggests
7. Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy
8. Epilepsy Drugs Dont Raise Suicide Risk, Study Shows
9. Study finds proximity could be key to success of healing prayer
10. Iron-regulating protein is strong predictor of breast cancer prognosis, study shows
11. New study examines the economic returns of public access policies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study shows physicians reluctant to use chemoprevention for prostate cancer
(Date:5/2/2015)... “ Peachtree Audio ” was featured on NewsWatch ... the latest and coolest technology products available to consumers. ... NewsWatch, conducted the review and shared with viewers how ... is an important part of people’s lives – and ... royal treatment. Peachtree Audio does just that with high-end ...
(Date:5/2/2015)... As a nonsurgical staple in ... face, neck and décolleté, radiofrequency energy is proving ... for the success of vulvovaginal rejuvenation. In a ... Council, ThermiGyn’s Women’s Health Clinical Advisory Board Chairman ... ThermiGyn’s temperature controlled radio frequency, specifically that of ...
(Date:5/1/2015)... Frisco, Texas (PRWEB) May 02, 2015 ... Frisco, Texas, is proud to announce the addition of ... Jen Widerstrom is a life long athlete, growing up ... fitness passion after college by becoming a personal trainer ... since been the face of several TV shows highlighting ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Jusuru International ... for the successful repositioning of its flagship nutritional supplement, ... brand with a new name, new logo, new packaging, ... Ethos Awards are designed to identify and promote programs ... best. , “DSA congratulates Jusuru International for their ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 TROY ... the Cerner Southeast Regional User Group (RUG) Conference in ... Cerner Southeast Regional User Group Conference provides a forum ... vendors who support all aspects of electronic medical record ... of Cerner software applications. , In addition to sponsoring ...
Breaking Medicine News(10 mins):Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... is an essential element of care for children requiring ... combining ketamine and propofol, two common medications used in ... it was unclear whether this practice was superior to ... Research led by Drs. Amit Shah, Gregory Mosdossy ...
... prostate cancer should be especially diligent about having routine ... at the University at Buffalo indicate. , Their findings ... more abnormal colon polyps, known as adenomas, and advanced ... of the research were presented Oct. 19 at a ...
... October 18, 2010 Neuralstem, Inc. (NYSE Amex: ... human clinical trial of the company,s spinal cord stem ... or Lou Gehrig,s disease) at Emory University in Atlanta, ... data from the first six non-ambulatory patients, the trial,s ...
... HealthDay Reporter , MONDAY, Oct. 18 (HealthDay ... victim to stunning medical mistakes, ranging from an operation ... for another patient, a new study finds. To ... Joint Commission in 2004 introduced a universal protocol for ...
... Mozes HealthDay Reporter , MONDAY, Oct. 18 (HealthDay ... may raise the risk for heart attack and stroke, researchers ... short-term, the study team noted. "I don,t want to ... cardiovascular risk in the period just after dental work was ...
... likely to buy unhealthy foods when they pay using ... in the Journal of Consumer Research . ... authors Manoj Thomas (Cornell University), Kalpesh Kaushik Desai (State ... University of New York, Buffalo). "First, there is a ...
Cached Medicine News:Health News:Study reveals superior sedation method for children 2Health News:Prostate cancer patients are at increased risk of precancerous colon polyps 2Health News:Neuralstem updates ALS clinical trial progress 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 3Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 4Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 3Health News:Cash is healthier? Credit and debit increase impulsive food purchases 2
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... of the "US ACO IT Spending Outlook 2018" ... expected that number of lives covered by ACO would ... In this report, the ACO IT spending has been ... spending on software and spending on services. Our research ...
(Date:5/1/2015)... Corporation (CYTR), a biopharmaceutical research and development company ... the three months ended March 31, 2015, and ... milestones for its clinical development programs. ... of 2015, including the announcement of encouraging data ... with soft tissue sarcoma, and positive interim data ...
(Date:5/1/2015)... -- Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) ... 31, 2015, as well as general business updates. Due ... will be held. Key Highlights , ... increased to $206 million from $119 million for the ... ® (ibrutinib) net product revenue of $247 million ...
Breaking Medicine Technology:United States ACO IT Spending Outlook 2014-2018 2CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25
... Pharmatek Laboratories, Inc., a premier contract development ... that it has added spray drying to its ... purchased a Buchi B-290 Mini Spray Dryer for ... technology can be used for both oral and ...
... 2011 Pharmasset, Inc. (Nasdaq: VRUS ), ... and commercializing novel drugs to treat viral infections, today ... ended March 31, 2011. Financial ... 31, 2011 compared to $0.3 million for the quarter ...
Cached Medicine Technology:Pharmatek Laboratories Adds Spray Drying to Drug Development Services 2Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2011 Financial Results 5
... The Hancock II bioprosthesis from Medtronic ... clinical experience. Worldwide clinical studies demonstrate that ... Hancock II aortic and mitral bioprostheses is ... valves. For more than 20 years, Medtronics ...
Attain Venogram Balloon Catheter....
... The A-Scan 100 is a compact, portable ultrasound ... to a Windows Laptop or PC computer. The ... performed using a single screen eliminating the need ... screens. , ,The automated features of the A-Scan ...
... touch screen control, automatic tone-assisted measurement & ... axial length measurements are almost effortless. Measuring ... Pseudophakic of Silicone, Acrylic, PMMA & other ... either contact or immersion mode & measurements ...
Medicine Products: